Marion E. Wolf

1.1k total citations
60 papers, 814 citations indexed

About

Marion E. Wolf is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Marion E. Wolf has authored 60 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 18 papers in Cellular and Molecular Neuroscience and 15 papers in Physiology. Recurrent topics in Marion E. Wolf's work include Neuropeptides and Animal Physiology (12 papers), Migraine and Headache Studies (8 papers) and Schizophrenia research and treatment (7 papers). Marion E. Wolf is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Migraine and Headache Studies (8 papers) and Schizophrenia research and treatment (7 papers). Marion E. Wolf collaborates with scholars based in United States, Chile and Egypt. Marion E. Wolf's co-authors include Aron D. Mosnaim, Javier Puente, Joseph J. Ryan, Seymour Diamond, Vasant Ranade, M. Antonieta Valenzuela, Owen Callaghan, Dante Miranda, Thomas J. Hudzik and William C. Koller and has published in prestigious journals such as JAMA, Diabetes and Biological Psychiatry.

In The Last Decade

Marion E. Wolf

58 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion E. Wolf United States 17 251 211 201 134 121 60 814
A Puech France 15 289 1.2× 258 1.2× 359 1.8× 112 0.8× 55 0.5× 46 1.0k
Peter H. Silverstone Canada 18 348 1.4× 182 0.9× 281 1.4× 64 0.5× 77 0.6× 30 912
R. J. Baldessarini United States 8 238 0.9× 133 0.6× 178 0.9× 51 0.4× 85 0.7× 10 658
V. Pedersen Denmark 14 272 1.1× 142 0.7× 260 1.3× 48 0.4× 104 0.9× 22 728
Stanley Slater United States 14 159 0.6× 130 0.6× 255 1.3× 90 0.7× 91 0.8× 31 1.0k
Lars Molander Sweden 16 150 0.6× 240 1.1× 124 0.6× 257 1.9× 39 0.3× 25 743
Matthew Butler United Kingdom 14 133 0.5× 220 1.0× 181 0.9× 182 1.4× 208 1.7× 40 769
Yoshio Morita Japan 17 136 0.5× 211 1.0× 248 1.2× 121 0.9× 74 0.6× 58 733
A. Reyntjens Belgium 11 191 0.8× 159 0.8× 264 1.3× 80 0.6× 39 0.3× 20 720
William M. Petrie United States 12 296 1.2× 119 0.6× 71 0.4× 107 0.8× 78 0.6× 33 839

Countries citing papers authored by Marion E. Wolf

Since Specialization
Citations

This map shows the geographic impact of Marion E. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion E. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion E. Wolf more than expected).

Fields of papers citing papers by Marion E. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion E. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion E. Wolf. The network helps show where Marion E. Wolf may publish in the future.

Co-authorship network of co-authors of Marion E. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Marion E. Wolf. A scholar is included among the top collaborators of Marion E. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion E. Wolf. Marion E. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mosnaim, Aron D., Thomas J. Hudzik, & Marion E. Wolf. (2015). Behavioral Effects of β-Phenylethylamine and Various Monomethylated and Monohalogenated Analogs in Mice Are Mediated by Catecholaminergic Mechanisms. American Journal of Therapeutics. 22(6). 412–422. 4 indexed citations
2.
Mosnaim, Aron D., Owen Callaghan, Thomas J. Hudzik, & Marion E. Wolf. (2013). Rat Brain-Uptake Index for Phenylethylamine and Various Monomethylated Derivatives. Neurochemical Research. 38(4). 842–846. 19 indexed citations
3.
Mosnaim, Aron D., et al.. (2010). Etiology and Risk Factors for Developing Orthostatic Hypotension. American Journal of Therapeutics. 17(1). 86–91. 25 indexed citations
4.
Mosnaim, Aron D., et al.. (2010). Degradation Kinetics of Methionine5-Enkephalin by Cerebrospinal Fluid: In Vitro Studies. American Journal of Therapeutics. 18(1). 9–13. 1 indexed citations
5.
Mosnaim, Aron D., et al.. (2008). Degradation Kinetics of Methionine5-Enkephalin by Select Brain Areas From Patients With Chronic Schizophrenia. American Journal of Therapeutics. 15(2). 126–130. 6 indexed citations
6.
Puente, Javier, et al.. (2008). Triptan Drugs, Natural Killer Cell Cytotoxicity, and Neutrophils Pro‐Matrix Metalloproteinase‐9 Secretion. Headache The Journal of Head and Face Pain. 48(10). 1482–1489. 14 indexed citations
7.
Mosnaim, Giselle, Claire Kohrman, Lisa K. Sharp, et al.. (2006). Coping with asthma in immigrant Hispanic families: a focus group study. Annals of Allergy Asthma & Immunology. 97(4). 477–483. 17 indexed citations
8.
Miranda, Dante, et al.. (2003). Lysis of Salmonella Typhi Intracellularly Infected U937 Cells by Human Natural Killer Cells: Effect of Protein Kinase Inhibitors. American Journal of Therapeutics. 10(1). 32–39. 3 indexed citations
9.
10.
Blanco, Luz P., Javier Puente, Carolina Carrasco, et al.. (2001). Effect of salmonella-infected human monocytes on natural killer cell cytotoxicity. In vitro studies. International Immunopharmacology. 1(7). 1285–1293. 4 indexed citations
11.
Wolf, Marion E., Vasant Ranade, János Molnár, John C. Somberg, & Aron D. Mosnaim. (2000). Hypercalcemia, Arrhythmia, and Mood Stabilizers. Journal of Clinical Psychopharmacology. 20(2). 260–264. 8 indexed citations
12.
Puente, Javier, Luz P. Blanco, Margarita Montoya, et al.. (2000). Effect of Salmonella typhi wild type and O-antigen mutants on human natural killer cell activity. International Journal of Immunopharmacology. 22(5). 355–364. 6 indexed citations
13.
Mosnaim, Aron D., et al.. (2000). Degradation Kinetics of Leucine5-Enkephalin by Plasma Samples from Healthy Controls and Various Patient Populations. American Journal of Therapeutics. 7(3). 185–194. 16 indexed citations
14.
Puente, Javier, et al.. (1997). ENHANCEMENT OF NATURAL KILLER CELL ACTIVITY IN HIV-1-INFECTED SUBJECTS BY A MIXTURE OF THE CALCIUM IONOPHORE A23187 AND THE PHORBOL ESTER TPA. American Journal of Therapeutics. 4(11). 413–422. 4 indexed citations
15.
Wolf, Marion E., et al.. (1997). LITHIUM THERAPY, HYPERCALCEMIA, AND HYPERPARATHYROIDISM. American Journal of Therapeutics. 4(9). 323–326. 19 indexed citations
16.
Mosnaim, Aron D., Shankar Huprikar, Marion E. Wolf, & Seymour Diamond. (1990). Platelet Monoamine Oxidase Activity in Female Migraine Patients. Headache The Journal of Head and Face Pain. 30(8). 488–490. 7 indexed citations
17.
Mosnaim, Aron D., Owen Callaghan, & Marion E. Wolf. (1989). Hydroxylation of phenylethylamine by rat liver preparations. Inhibition studies. General Pharmacology The Vascular System. 20(4). 463–467. 3 indexed citations
18.
Mosnaim, Aron D., et al.. (1988). Studies of the in vitro human plasma degradation of methionine-enkephalin. General Pharmacology The Vascular System. 19(5). 729–733. 21 indexed citations
19.
Wolf, Marion E., et al.. (1983). Phenylethylamine-Like Properties of Baclofen. Neuropsychobiology. 9(4). 219–222. 5 indexed citations
20.
Mosnaim, Aron D. & Marion E. Wolf. (1978). Phenylethylamine : biological mechanisms and clinical aspects. M. Dekker eBooks. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Puech Breakdown of academic impact, for papers by Peter H. Silverstone Breakdown of academic impact, for papers by R. J. Baldessarini Breakdown of academic impact, for papers by V. Pedersen Breakdown of academic impact, for papers by Stanley Slater Breakdown of academic impact, for papers by Lars Molander Breakdown of academic impact, for papers by Matthew Butler Breakdown of academic impact, for papers by Yoshio Morita Breakdown of academic impact, for papers by A. Reyntjens Breakdown of academic impact, for papers by William M. Petrie
Rankless by CCL
2026